论文部分内容阅读
Objective:To study the diagnostic value of multiple tumor markers in malignant ovarian neoplasm.Methods:Sera obtained from 430 patients with ovarian masses (110 cases were malignant ovarian tumors,320 cases were benign ovarian tumors) before operation,and from 50 healthy women as control.Serologic examination of tumor markers included CA125,TSGF,SA,CEA,AFP,HCG and Fer.Results:The serum levels of CA125,TSGF,SA and Fer in patients with ovarian cancer were higher than those in patients with benign ovarian tumors (P<0.05),also in control group (P<0.05).In the diagnostic value of application for malignant ovarian neoplasm,CA125,TSGF and SA were better than the others.The sensitivity,specificity and accuracy in diagnosis of ovarian cancer were 86.4%,82.8%and 83.7% respectively for CA125 alone,78.2%,81.3%and 80.5% for TSGF alone,74.5%,81.9%and 80.0% for SA alone,whereas 95.5%,45.6%and 58.4% for multiple tumor markers combined in which 1 or more indices showed positive,93.6%,80.6%and 84.0% for that in which 2 or more indices showed positive,and 87.3%,90.3%and 89.5% for that in which 3 or more indices show positive.Conclusion:multiple tumor markers examination could improve the diagnosis of ovarian cancer,and examination of CA125,TSGF and SA combined is most ideal.
Objective: To study the diagnostic value of multiple tumor markers in malignant ovarian neoplasm. Methods: Sera obtained from 430 patients with ovarian masses (110 cases were malignant ovarian tumors, 320 cases were benign ovarian tumors) before operation, and from 50 healthy women as control. Serologic examination of tumor markers included CA125, TSGF, SA, CEA, AFP, HCG and Fer. Results: The serum levels of CA125, TSGF, SA and Fer in patients with ovarian cancer were higher than those in in patients with benign ovarian tumors (P <0.05), also in control group (P <0.05) .In the diagnostic value of application for malignant ovarian neoplasm, CA125, TSGF and SA were better than the others. Sensitivity, specificity and accuracy in diagnosis of ovarian cancer were 86.4%, 82.8% and 83.7% respectively for CA125 alone, 78.2%, 81.3% and 80.5% for TSGF alone, 74.5%, 81.9% and 80.0% for SA alone, while 95.5%, 45.6% and 58.4% for multiple tumor markers combined in which 1 or more indices showed positive, 93.6%, 80.6% and 84.0% for that in which 2 or more indices showed positive, and 87.3%, 90.3% and 89.5% for that in which 3 or more indices show positive. Confclusion: multiple tumor markers examination could improve the diagnosis of ovarian cancer, and examination of CA125, TSGF and SA combined is most ideal.